South & Central America Flowable Hemostats Market Forecast to 2028

South & Central America Flowable Hemostats Market Forecast to 2028

South & Central America Flowable Hemostats Market Forecast to 2028 – Regional Analysis – by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)

Send Enquiry
Item ID: BMIRE00029828 Category: Tag:

$2,485 – $3,885

Description

The South & Central America flowable hemostats market is expected to grow from US$ 40.12 million in 2022 to US$ 48.41 million by 2028. It is estimated to grow at a CAGR of 3.2% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel South & Central America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon’s (Johnson & Johnson Medical Device Companies) new product, “SURGIFLO Hemostatic Matrix.” SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

South & Central America Flowable Hemostats Market Overview

South and Central America include Brazil, Argentina, and the Rest of South and Central America. The market for flowable Hemostats in the region is expected to grow owing to the growing adoption of flowable hemostats, increasing number of surgical procedures, and growing emphasis on blood-loss management strategies during surgical procedures. In addition, the implementation of organic strategies by major market players is also boosting the product reach and awareness in the region, leading to considerable growth the of flowable hemostats market in South and Central America. The adoption of flowable hemostats in Brazil is attributed to favorable government policies, growing emphasis on blood loss management during surgical procedures, and awareness of the benefits offered by flowable hemostats. Additionally, lucrative government policies and market potential are attracting global as well as local players to launch their products in the country. For instance, in 2015, 3D-Matrix, one of the considerable players in the hemostats market obtained product approval for its PureStat hemostat to commercialize it in the Brazil market. Furthermore, the higher number of surgical procedures are also expected to fuel the growth of Brazil flowable hemostats market. For instance, according to data published by the Ministry of Health, Brazil, the number of elective surgeries grew by an estimated 49.2% from January 2019 to September 2019. Such growth in the number of surgeries is likely to drive the growth of the hemostats market by 2028.

South & Central America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Flowable Hemostats Market Segmentation

The South & Central America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the South & Central America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the South & Central America flowable hemostats market in 2022.

In terms of product, the South & Central America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the South & Central America flowable hemostats market in 2022.

Based on application, the South & Central America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the South & Central America flowable hemostats market in 2022.

Based on end user, the South & Central America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the South & Central America flowable hemostats market in 2022.

By country, the South & Central America flowable hemostats market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the South & Central America flowable hemostats market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 3.2% CAGR, the South & Central America Flowable Hemostats Market is Speculated to be Worth US$ 48.41 Million by 2028, Says the Research Team

According to the Research Team’ research, the South & Central America flowable hemostats market was valued at US$ 40.12 million in 2022 and is expected to reach US$ 48.41 million by 2028, registering a CAGR of 3.2% from 2022 to 2028. Increasing number of hospitals and surgical centers and rising geriatric population are among the critical factors attributed to the South & Central America flowable hemostats market expansion.

The number of hospitals and surgical centers is increasing rapidly in developed and emerging regions. Such growth accelerates demand for surgical equipment (including medical devices and hemostat products) for lately established surgical centers and hospitals. Furthermore, the growth in the healthcare sector offers lucrative opportunities for the flowable hemostats market. The healthcare industry has been encountering a rapid transformation in recent years. Various countries across the globe have favored advanced technologies in healthcare. With the need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being referred to in the healthcare systems, especially in emerging economies. Some of the primary factors, such as rising incidences of chronic illnesses, an increase in the aging population, and pediatric care, are helping boost the growth of the healthcare industry. With rising technical procedures, the effectiveness of topical hemostats may help improve clinical outcomes. Thus, the ideal topical hemostats would offer authentic and prompt bleeding control. Such significant growth in the number of hospitals and surgical centers demands high adoption of flowable hemostat products, ultimately offering lucrative growth opportunities for the market’s growth during the coming years.

On the contrary, shortage of skilled professionals and poor reimbursement policies hamper the South & Central America flowable hemostats market.

Based on material, the South & Central America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held 62.8% share of South & Central America flowable hemostats market in 2022, amassing US$ 25.19 million. It is projected to garner US$ 30.75 million by 2028 to expand at 3.4% CAGR during 2022-2028.

In terms product, the South & Central America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held 58.0% share of South & Central America flowable hemostats market in 2022, amassing US$ 23.27 million. It is projected to garner US$ 28.65 million by 2028 to expand at 3.5% CAGR during 2022-2028.

Based on application, the South & Central America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held 32.5% share of South & Central America flowable hemostats market in 2022, amassing US$ 13.03 million. It is projected to garner US$ 16.68 million by 2028 to expand at 4.2% CAGR during 2022-2028.

Based on end user, the South & Central America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held 64.7% share of South & Central America flowable hemostats market in 2022, amassing US$ 25.95 million. It is projected to garner US$ 31.07 million by 2028 to expand at 3.0% CAGR during 2022-2028.

By country, the South & Central America flowable hemostats market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 55.3% share of South & Central America flowable hemostats market in 2022. It was assessed at US$ 22.20 million in 2022 and is likely to hit US$ 27.97 million by 2028, exhibiting a CAGR of 3.9% during 2022-2028.

Key players operating in the South & Central America flowable hemostats market Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences, among others.

In Dec-19, Johnson & Johnson’s Ethicon unit has launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures. According to Ethicon, it’s the first fibrin sealant designed to be used without a gas propellant. Delivered in a pre-filled syringe, the spray is designed to rapidly adhere and form a clot over the bleed and has shown clinical success in high-risk patients-such as those with multiple factors including bleeding disorders, diabetes or organ failure, or patients taking blood thinners or antiplatelet therapies.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America flowable hemostats market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America flowable hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 the Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Flowable Hemostats Market – By Material
1.3.2 South & Central America Flowable Hemostats Market – By Product
1.3.3 South & Central America Flowable Hemostats Market – By Application
1.3.4 South & Central America Flowable Hemostats Market – By End User
1.3.5 South & Central America Flowable Hemostats Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Flowable Hemostats Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 South & Central America Experts Opinion
5. South & Central America Flowable Hemostats Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Injuries and Surgical Procedures
5.1.2 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis
6. Flowable Hemostats Market – South & Central America Analysis
6.1 South & Central America Flowable Hemostats Market Revenue Forecast & Analysis
6.1.1 South & Central America Flowable Hemostats Market Revenue Forecast & Analysis
7. South & Central America Flowable Hemostats Market Analysis – By Material
7.1 Bovine Gelatin
7.1.1 Overview
7.1.2 Bovine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.2 Porcine Gelatin
7.2.1 Overview
7.2.2 Porcine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Flowable Hemostats Market- By Product
8.1 Overview
8.2 Combination Hemostat
8.2.1 Overview
8.2.2 Combination Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.3 Passive Hemostat
8.3.1 Overview
8.3.2 Passive Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Active Hemostat
8.4.1 Overview
8.4.2 Active Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Flowable Hemostats Market- By Application
9.1 Overview
9.2 General Surgery
9.2.1 Overview
9.2.2 General Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiac Surgery
9.3.1 Overview
9.3.2 Cardiac Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Vascular Surgery
9.4.1 Overview
9.4.2 Vascular Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Orthopedic Surgery
9.5.1 Overview
9.5.2 Orthopedic Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Neuro and Spine Surgery
9.6.1 Overview
9.6.2 Neuro and Spine Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Flowable Hemostats Market Analysis – By End User
10.1 Overview
10.2 South & Central America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgery Centers
10.4.1 Overview
10.4.2 Ambulatory Surgery Centers: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Flowable Hemostats Market Revenue and Forecasts to 2028 – Country Analysis
11.1 South & Central America Flowable Hemostats Market Revenue and Forecasts To 2028
11.1.2 South & Central America: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
11.1.2.1 Brazil
11.1.2.1.1 Brazil: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.1.2 Brazil: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 Brazil: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 Brazil: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 Brazil: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Argentina
11.1.2.2.1 Argentina: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.2.2 Argentina: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Argentina: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Argentina: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Argentina: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 Rest of South & Central America
11.1.2.3.1 Rest of South & Central America: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.3.2 Rest of South & Central America: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 Rest of South & Central America: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 Rest of South & Central America: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 Rest of South & Central America: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
12. Flowable Hemostats Market-Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Teleflex Incorporated
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aegis Lifesciences
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 South & Central America Glossary of Terms

LIST OF TABLES

Table 1. Brazil: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South & Central America: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South & Central America: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South & Central America: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South & Central America: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Flowable Hemostats Market
Table 14. Inorganic Developments in the Flowable Hemostats Market
Table 15. South & Central America Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Flowable Hemostats Market Segmentation
Figure 2. South & Central America Flowable Hemostats Market, By Country
Figure 3. South & Central America Flowable Hemostats Market Overview
Figure 4. Bovine Gelatin Holds Maximum Share in South & Central America Flowable Hemostats Market
Figure 5. South & Central America Flowable Hemostats Market, by Country (US$ Million)
Figure 6. South & Central America Flowable Hemostats Market, Market Attractiveness
Figure 7. South & Central America: PEST Analysis
Figure 8. South & Central America Experts Opinion
Figure 9. Impact Analysis
Figure 10. South & Central America Flowable Hemostats Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. South & Central America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
Figure 12. Bovine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Porcine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. South & Central America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
Figure 15. Combination Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Passive Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Active Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. South & Central America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
Figure 19. General Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiac Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Vascular Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Orthopedic Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuro and Spine Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. Hospitals and Clinics: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Ambulatory Surgery Centers: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 29. South & Central America: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
Figure 30. Brazil: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 31. Argentina: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 32. Rest of South & Central America: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Growth Strategies in the Flowable Hemostats Market (%)

The List of Companies – South & Central America Flowable Hemostats Market

1. Baxter International Inc
2. Ethicon (Johnson & Johnson)
3. Pfizer Inc.
4. Teleflex Incorporated
5. 3-D Matrix Medical Technology
6. Aegis Lifesciences

Reviews

There are no reviews yet.

Be the first to review “South & Central America Flowable Hemostats Market Forecast to 2028”